ArticleHuman vaccines & immunotherapeutics2018
Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Drivers of human papillomavirus vaccine uptake in migrant populations and interventions to improve coverage: a systematic review and meta-analysis.The Lancet. Public health · 2025Pooled it
- Factors Affecting Human Papillomavirus Vaccination in Men: Systematic Review.JMIR public health and surveillance · 2022Pooled it
- Efficacy of the Outsmart HPV Intervention: A Randomized Controlled Trial to Increase HPV Vaccination among Young Gay, Bisexual, and Other Men Who Have Sex with Men.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023Trial
- Human Papillomavirus vaccination clinical decision support for young adults in an upper midwestern healthcare system: a clinic cluster-randomized control trial.Human vaccines & immunotherapeutics · 2022Trial
- Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020.Human vaccines & immunotherapeutics · 2026Article
- Occupational HPV exposure and vaccination among healthcare workers: Implications for institutional vaccination strategies.Human vaccines & immunotherapeutics · 2026Article
- Article
- Article
- Cervical cancer prevention behaviors and determinants among Indigenous women in rural Nepal.Health promotion international · 2026Article
- Human Papillomavirus Vaccine Perceptions Among Noncollege Young Adults and TikTok Influencers: Qualitative Study.JMIR formative research · 2026Article
- Review
- A comprehensive review of HPV vaccination policies in the United States.Frontiers in public health · 2026Review
- Awareness of HPV, HPV vaccine and HPV-associated cancers among Arab Americans.Scientific reports · 2025Article
- Article
- Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake.Frontiers in public health · 2025Article
- Identifying the Gaps in Human Papillomavirus (HPV) Vaccine Uptake: An Exploratory Factor Analysis of Adults in Tennessee.Vaccines · 2024Article
- Pap test recency and HPV vaccination among Brazilian immigrant women in the United States: a cross-sectional study.BMC public health · 2024Article
- Demographic Influences on Adult HPV Vaccination: Results from a Cross-Sectional Survey in Tennessee.Healthcare (Basel, Switzerland) · 2024Article
- Factors associated with HPV-associated sexual risk behaviors among sexually active college students.Journal of behavioral medicine · 2024Article
- Examining HPV vaccination behavior among young adults: Insights from applying the Health Belief Model.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine correlates of HPV vaccination uptake in a nationally representative sample of 18-26-year-old adults.
methodsYoung adults aged 18-26 years were identified from the 2014 and 2015 National Health Interview Survey (n = 7588). Survey-weighted multivariable logistic regression models estimated sociodemographic factors associated with HPV vaccine initiation (≥1 dose) and completion (≥3 doses).
resultsApproximately 27% of study participants had initiated the HPV vaccine and 16% had completed the HPV vaccine. Participants were less likely to initiate the vaccine if they were men [(adjusted odds ratio) 0.19; (95% confidence interval) 0.16-0.23], had a high school diploma (0.40; 0.31-0.52) or less (0.46; 0.32-0.64) vs. college graduates, and were born outside the United States (0.52; 0.40-0.69). But, participants were more likely to initiate the HPV vaccine if they visited the doctor's office 1-5 times (2.09; 1.56-2.81), or ≥ 6 times (1.86; 1.48-2.34) within the last 12 months vs. no visits. Odds of completing HPV vaccine uptake followed the same pattern as initiation. And after stratifying the study population by gender and foreign-born status, these variables remained statistically significant.
conclusionsIn our nationally representative study, only one out of six 18-26 year olds completed the required vaccine doses. Men, individuals with high school or less education, and those born outside the United States were less likely to initiate and complete the HPV vaccination. Our findings suggest that it may be useful to develop targeted interventions to promote HPV vaccination among those in the catch-up age range.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.